The EMA has launched a consultation on the circumstances in which single-arm trials (SATs) – those without a control group – can be used to support marketing applications
Benchling has seen its business grow at a healthy lick since it launched in 2012 with a mission to improve the efficiency of the biopharma R&D process, but it looks li
The biopharma industry has lost another leading figure with the passing of Andy Zoltners, co-founder of ZS Associates, on the 40th anniversary of the company.
Bristol-Myers Squibb has formed another alliance focusing on antibody-drug conjugates (ADCs) for solid tumours, paying German biotech Tubulis $22.75 million upfront to get
Moderna and IBM have formed a partnership to see how cutting-edge technologies like generative artificial intelligence and quantum computing could be applied to the discov
Johnson & Johnson was preparing to divulge the data from its eagerly-awaited CARTITUDE-4 trial of CAR-T therapy Carvykti later this year, but a leak of the data has gi